Related Experiment Videos

STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma

Xin-Hong Wang1, Xiang-Wei Meng, Hui Xing

  • 1Department of Gastroenterology, The Second Affiliated Hospital of Harbin Medical University, Harbin, HeiLongJiang Province, China.

Hepato-Gastroenterology
|June 14, 2011
PubMed
Abstract

Insights

This study investigated the roles of beta-catenin and STAT3 signaling in hepatocellular carcinoma (HCC). Results indicate these pathways influence GSK-3beta expression, crucial for HCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Understanding the molecular pathways driving HCC is critical for developing targeted therapies.

Purpose of the Study:

  • To elucidate the correlation and significance of beta-catenin, STAT3, and GSK-3beta signaling pathways in HCC.
  • To investigate the regulatory roles of beta-catenin and STAT3 in HCC progression.

Main Methods:

  • Utilized the HepG2 HCC cell line for experimental manipulation.
  • Employed small interfering RNA (siRNA) to silence beta-catenin and STAT3 expression.
  • Analyzed protein expression levels of beta-catenin, STAT3, and GSK-3beta using Western blot analysis at 72 and 96 hours post-transfection.

Main Results:

  • Silencing beta-catenin led to decreased beta-catenin and increased GSK-3beta/p-GSK-3beta protein expression, with no change in STAT3.
  • Silencing STAT3 resulted in decreased STAT3 expression and altered beta-catenin and GSK-3beta/p-GSK-3beta levels over time.
  • These findings suggest complex cross-regulation between these signaling molecules in HCC cells.

Conclusions:

  • The beta-catenin signaling pathway appears to regulate GSK-3beta protein expression in HCC.
  • The STAT3 signaling pathway may modulate both beta-catenin and GSK-3beta expression.
  • These pathways play pivotal roles in the pathogenesis and progression of hepatocellular carcinoma.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...